Published in J Hepatol on December 01, 1994
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis (1991) 6.69
Naturally occurring auxin transport regulators. Science (1988) 6.20
Computer aided diagnosis of acute abdominal pain: a multicentre study. Br Med J (Clin Res Ed) (1986) 5.49
Basal localization of the presumptive auxin transport carrier in pea stem cells. Science (1983) 4.59
Carcinoid tumour. Lancet (1998) 4.52
Two Cases of Thromboembolic Disease Associated with Oral Contraceptives. Br Med J (1962) 4.49
Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill (2009) 4.23
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Breast-milk substitutes--a South African perspective urgently needed. S Afr Med J (1995) 3.98
Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ (1997) 3.72
Child resistant containers needed for liquid medications. BMJ (1993) 3.42
The critical attitude in medicine: the need for a new ethics. Br Med J (Clin Res Ed) (1984) 3.41
Clinical-histopathological correlation of the abnormal retinal vessels in cerebral malaria. Arch Ophthalmol (2000) 2.97
Differential interactions of promoter elements in stress responses of the Arabidopsis Adh gene. Plant Physiol (1994) 2.92
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
THE UTILIZATION OF INTRAVENOUSLY INJECTED SALT IN NORMALS AND IN PATIENTS WITH CUSHING'S SYNDROME BEFORE AND AFTER ADMINISTRATION OF DESOXYCORTICOSTERONE ACETATE. J Clin Invest (1944) 2.64
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
Intestinal factors in the control of insulin secretion. J Clin Endocrinol Metab (1965) 2.32
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Br J Surg (2012) 2.17
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12
Low levels of zinc in hair, anorexia, poor growth, and hypogeusia in children. Pediatr Res (1972) 2.12
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology (2003) 2.10
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg (2004) 2.05
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
"Salvage" transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology (1998) 1.95
Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol (2002) 1.92
Simulating the diabetic environment modifies in vitro prostacyclin synthesis. Diabetes (1983) 1.90
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology (2002) 1.90
MAGNESIUM PARTITION STUDIES IN GRAVES' DISEASE AND IN CLINICAL AND EXPERIMENTAL HYPOTHYROIDISM. J Clin Invest (1941) 1.89
An appraisal of the histopathological assessment of liver fibrosis. Gut (2006) 1.87
Systematic review: The model for end-stage liver disease--should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther (2005) 1.86
Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry (1997) 1.86
Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg (2000) 1.85
3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J (1998) 1.83
French lessons on surveillance of communicable diseases. Br Med J (Clin Res Ed) (1987) 1.79
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol (1999) 1.76
Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet (2000) 1.75
A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke (1995) 1.75
Conformation and molecular mechanisms of carriers and channels. Ann N Y Acad Sci (1975) 1.74
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med (1992) 1.72
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol (2001) 1.66
Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut (1998) 1.63
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev (2006) 1.63
Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry. Eur J Vasc Endovasc Surg (2006) 1.63
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost (2010) 1.62
Cloning, sequencing and expression of subtilisin Carlsberg from Bacillus licheniformis. Nucleic Acids Res (1985) 1.61
Transjugular liver biopsy: how good is it for accurate histological interpretation? Gut (2006) 1.61
Norwegian scabies and a toxic shock syndrome toxin 1-producing strain of Staphylococcus aureus endocarditis in a patient with trisomy 21. Clin Infect Dis (1998) 1.60
Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol (1999) 1.60
Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature (1987) 1.60
Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther (2005) 1.59
Clinicopathological investigation of primary, uncomplicated maedi-visna virus infection. Vet Rec (1992) 1.59
Warfarin induced skin necrosis. Br J Surg (2000) 1.57
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology (1998) 1.57
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Aliment Pharmacol Ther (2013) 1.56
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Ann Oncol (2010) 1.55
Life-style modification in peripheral arterial disease. Eur J Vasc Endovasc Surg (2005) 1.53
Azathioprine in liver transplantation: a reevaluation of its use and a comparison with mycophenolate mofetil. Am J Transplant (2009) 1.52
Posterior lenticonus: clinical patterns and genetics. J Pediatr Ophthalmol Strabismus (1993) 1.49
Diurnal pattern of variceal bleeding in cirrhotic patients. J Hepatol (1993) 1.47
Fatal arrhythmia after pulse methylprednisolone therapy. Ann Intern Med (1981) 1.47
Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years. Am J Transplant (2006) 1.47
Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.46
Tublin: nucleotide binding and enzymic activity. J Mol Biol (1974) 1.46
Is Mycoplasma hominis a vaginal pathogen? Sex Transm Infect (2001) 1.46
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol (2004) 1.45
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Aortic aneurysm repair in a renal transplant patient: preservation of renal function. Eur J Vasc Surg (1991) 1.44
Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease. Int J Cardiol (1999) 1.43
Critique of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): flaws in CREST and its interpretation. Eur J Vasc Endovasc Surg (2013) 1.42
Acid-base and electrolyte abnormalities observed in patients receiving cardiovascular drugs. J Cardiovasc Pharmacol Ther (2003) 1.41
Experimental reduction of portal hypertension by mechanical increase of liver portal flow. Lancet (1991) 1.40
Tacrolimus exposure after liver transplantation in randomized controlled trials: too much for too long. Am J Transplant (2013) 1.40
Systematic review of radiological imaging for hepatocellular carcinoma in cirrhotic patients. Br J Radiol (2004) 1.40
Infection, coagulation, and variceal bleeding in cirrhosis. Gut (2005) 1.39
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia. Atherosclerosis (2000) 1.39
Prevalence and predictors of persistent health status impairment in patients referred to a vascular clinic with intermittent claudication. Eur J Vasc Endovasc Surg (2011) 1.39
Staple-line erosion: a common source of recurrent bleeding following stapled oesophageal transection. Br J Surg (1991) 1.39